By Dorothy Ogwuru, Founder, PharmaLink Academy. 18 years in pharmacovigilance and regulatory medical writing, including as a Senior Regulatory Medical Writer and at Global Head of Pharmacovigilance level. Last updated 8 June 2026.

The honest one-line difference

Regulatory medical writing serves regulators. Medical communications serves prescribers. Everything else flows from that.

A regulatory medical writer produces the documents a sponsor submits to the MHRA, the EMA or the FDA to seek approval for a medicine to be sold. Clinical Study Reports, Common Technical Document Module 2 summaries, Investigator's Brochures, regulatory responses. The reader is a regulator. The standard is regulatory-grade precision under defined timelines.

A medical communications writer produces the materials a sponsor uses to communicate with prescribers, patients and the wider scientific community once a medicine is approved or about to be. Scientific publications, congress posters, slide decks, advisory board reports, training modules, patient education materials. The reader is a healthcare professional or patient. The standard is clarity, accuracy and persuasive scientific narrative.

Both are real careers. Both are well paid. They are not the same job.

Side-by-side: the data that matters when choosing

Which route fits which background

The honest pattern across the 200-plus candidates I have mentored or worked with over 13 years.

The honest trade-offs nobody mentions

Regulatory medical writing pays more, but the work environment is more constrained. Document timelines do not negotiate with personal calendars. Submission peaks are real and unavoidable. The professional standing inside a sponsor company is significant, but so is the expectation of precision.

Medical communications offers more variety, broader exposure, and a faster path into industry, but the ceiling is lower. The senior career trajectory caps closer to Director than to Vice President. Agency-side medical comms also exposes you to client pressure that sponsor regulatory writers rarely feel, because the agency is being commercially evaluated on every deliverable.

The career portability difference matters more than candidates realise at the entry decision. Regulatory medical writing skills transfer cleanly to the United States, the European Union, the United Arab Emirates, Saudi Arabia, Singapore and Japan with minimal retraining, because every market regulates medicines through similar frameworks. Medical communications expertise is more market-specific because publication norms, congress structures, and prescriber audiences vary by region.

The realistic crossover route

Crossing from medical communications into regulatory medical writing is more common than the reverse. Roughly 15 to 20 per cent of working regulatory medical writers in the UK started in medical communications and crossed over after 2 to 5 years. The reverse crossover is rare; regulatory writers who move into medical comms usually do so to step into agency leadership or to pivot toward consultancy.

If you are uncertain and want to keep the door open both ways, medical communications first then regulatory is the safer sequence. The regulatory-first route is the higher-conviction play if the regulatory document type is what genuinely appeals.

The training implication

The two routes demand different portfolio evidence at hire.

A regulatory medical writing employer wants worked Clinical Study Report sections, Module 2.7 drafts, and Investigator's Brochure updates. That is what the writing assessment tests for, and it is what the interview probes. Without that evidence, applications stall regardless of underlying clinical or scientific background.

A medical communications employer wants publications, posters, congress slides, scientific summaries written for prescriber audiences, and the ability to adapt voice across formats. Strong publication track records often substitute for formal training; the writing assessment is shorter and the bar is lower.

Where PharmaLink Academy fits

PharmaLink Academy trains for the regulatory route. The Regulatory Medical Writing programme builds the worked CSR sections, Module 2 summaries and Investigator's Brochure drafts that UK and Gulf sponsor companies and CROs hire on. The programme is intentionally not pitched at medical communications candidates, because the portfolio evidence required is different.

For candidates better suited to medical communications, the credible UK training providers are EMWA (the European Medical Writers Association) which runs short courses at the entry level, ISMPP for advanced publication writing, and the in-house training programmes at the larger medical communications agencies (Ashfield MedComms, Open Health, Envision Pharma) which typically hire junior writers and train them on the job.

Related decisions for the pivot

The medical writing route choice sits inside a broader career pivot. If you are still weighing whether the move into pharma is right for you at all, Is a Pharma Career Right for You is the honest filter to read first. For the specific UK regulatory medical writing job market, see Regulatory Medical Writing Jobs UK 2026. For the side-by-side between regulatory medical writing and pharmacovigilance as the two main industry-side roles, see Regulatory Medical Writing vs Pharmacovigilance.

Frequently asked questions

Which pays more in the UK, regulatory medical writing or medical communications? Regulatory medical writing pays more at every level. Year 1 sponsor regulatory medical writer earns roughly £45,000 to £65,000 versus £38,000 to £48,000 in medical communications. The gap widens at senior level: £85,000 to £125,000 versus £70,000 to £90,000 at Year 5. Director-level regulatory medical writing exceeds £120,000 with equity at sponsor companies; agency medical comms typically caps at £90,000 to £120,000.

Which is easier to break into without prior pharma experience? Medical communications, by a meaningful margin. Medical comms agencies hire on publication record, writing samples, and scientific background. Regulatory medical writing hires on a worked portfolio of regulatory documents, which most candidates do not have without specific training. The hiring cycle is also shorter for medical communications.

Can I move from medical communications into regulatory medical writing later? Yes, and it is the most common crossover route. Roughly 15 to 20 per cent of working UK regulatory medical writers started in medical communications. The reverse move (regulatory into medical comms) is rarer and usually motivated by a step into agency leadership or consultancy.

Are medical communications jobs remote in the UK? Mostly yes, often fully remote at the senior level. Agencies typically meet for quarterly in-person events. Regulatory medical writing is more hybrid; sponsor companies often expect 2 to 3 days in office, CROs 1 to 2 days.

Do I need a PhD for either career? No, for either. The majority of working medical writers in both routes hold a BSc or MSc in a life sciences discipline. A PhD can shortcut a first interview because it signals comfort with structured scientific writing, but it does not replace ICH fluency for regulatory roles or publication writing capability for medical comms.

Which route has better career portability internationally? Regulatory medical writing. The regulatory frameworks across the UK, EU, US, Gulf and Asia share enough common structure (ICH guidelines, CTD format) that experienced regulatory medical writers transfer with minimal retraining. Medical communications is more market-specific because prescriber audiences and publication norms vary by region.